Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding.
Andrea B ApoloChristine Michaels-IgbokweNicholas I SimonDavid J BenjaminMallory FarrarZsolt HeppLisa MuchaSebastian HeidenreichKatelyn CuttsNicolas KrucienNatasha RamachandranJohn L GorePublished in: The patient (2024)
Of the attributes tested, changes in ORR were most important to patients. Patients made tradeoffs between treatment attributes indicating that a lower ORR may be acceptable for an improvement in other attributes such as reduced cancer-related pain or the risk of treatment-related adverse events.